Modulation of Prolactin Secretion at the Pituitary Level: Involvement of Adenylate Cyclase

  • Alain Enjalbert
  • Joël Bockaert
  • Jacques Epelbaum
  • Emmanuel Moyse
  • Claude Kordon
Part of the Biochemical Endocrinology book series (BIOEND)


The original concept of adenohypophyseal regulation postulated that exteroceptive and interoceptive inputs were integrated at the hypothalamic level and relayed to the pituitary in the form of simple messages. The hypophysis was thus considered a passive responder to such messages which increased or reduced hormonal secretion. It appears now that the situation is more complex in particular for prolactin secretion.


Dopamine Receptor Adenylate Cyclase Vasoactive Intestinal Peptide Ergot Alkaloid Prolactin Secretion 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Arancibia, S., Enjalbert, A., Ruberg, M., Priam, M., Bluet-Pajot, M. T., and Kordon, C., 1981, Activité PRF (prolactin releasing factor) du VIP (vasoactive intestinal peptide) in vitro, J. Physiol. (Paris), 77: 979.Google Scholar
  2. Barnes, G. D., Brown, B. L., Gard, T. G., Atkinson, D., and Ekins, R. P., 1978, Effect of TRH and dopamine on cyclic AMP levels in enriched mammotroph and tyrotroph cells, Mol. Cell. Endocr., 12: 275.Google Scholar
  3. Bataille, D., Peillon, F., Besson, J., and Rosselin, G., 1979, Vasoactive intestinal peptide (VIP): Récepteurs spécif iques et activation de l’adénylate cyclase dans une tumeur hypophysaire humaine à prolactine, C. R. Acad. Sci. ( Paris ), 288: 1315.Google Scholar
  4. Bauer, K., Graf, K. J., Faivre-Bauman, A., Beier, S., TixierVidal, A., and Kleinkauf, M., 1978, Inhibition of prolactin secretion by histidyl-proline-diketopiperazine. Nature, 274: 174.PubMedCrossRefGoogle Scholar
  5. Bicknell, R. J., Young, P. W., Schofield, J. G., and Albano, J., 1977, Mechanism of action of somatostatin: Growth hormone release, [45Ca] calciuth ion efflux and cyclic nucleotidesGoogle Scholar
  6. metabolism of bovine anterior-pituitary slices in the presence of prostaglandin E2 and L-methyl-3-isobutylxanthine, Biochem. Soc. Trans., 5: 219.Google Scholar
  7. Borgeat, P., Labrie, F., Drouin, J., Belanger, A., Immer, I., Seetany, K., Nelson, V., Grotz, M., Schally, A. V., Coy, D. H., and Coy, E. J., 1974, Inhibition of adenosine 3’, 5’ monophosphate accumulation in anterior pituitary gland in vitro by growth hormone release inhibiting hormone, Biochem. Biophys. Res. Commun., 56: 1052.Google Scholar
  8. Caron, M. G., Beaulieu, M., Raymond, V., Gagné, B., Drouin, J., Lefkowitz, R., and Labrie, F., 1978, Dopaminergic receptors in the anterior pituitary gland, J. Biol. Chem., 253: 2244.Google Scholar
  9. Cheung, C. Y., 1982, Beta-endorphin modulates the dopamine inhibi- tion of prolactin secretion at the anterior pituitary, in: 12th Neuroscience Meeting, Abstract N°18.1.Google Scholar
  10. Cronin, M. J., Myers, G. A., Dabney, L. G., and Hewlett, E. L., 1982, Pertussis toxin uncouples dopamine receptor-mediated inhibition of prolactin release, in: 64th Annual Meeting of the Endocrine Society.Google Scholar
  11. Cronin, M. J., and Weiner, R. I., 1979, [3H]-spiroperidol (spiperone) binding to a putative dopamine receptor in sheep and steer pituitary and stalk median eminence, Endocrinology, 104: 307.Google Scholar
  12. De Camilli, P., Macconi, D., and Spada, A., 1979, Dopamine inhibits adenylate cyclase in human prolactin secreting pituitary adenomas, Nature, 278: 252.PubMedCrossRefGoogle Scholar
  13. De Lean, A., Kilpatrick, B. F., and Caron, M. G., 1982, Guanine nucleotides regulate both dopaminergic agonist and antagonist binding in porcine anterior pituitary, Endocrinology, 110: 1064.PubMedCrossRefGoogle Scholar
  14. Drouin, J., De Lean, A., Rainville, D., Lachance, R., and Labrie, F., 1976, Characteristics of the interaction between thyrotropin releasing hormone and somatostatin for thyrotropin and prolactin release, Endocrinology, 98: 514.PubMedCrossRefGoogle Scholar
  15. Enjalbert, A., 1982, Multiplicité des facteurs qui influencent la sécrétion de prolactine au niveau hypophysaire, in: “ Prolactine, Neurotransmission et Fertilité ”, Masson, Paris.Google Scholar
  16. Enjalbert, A., Arancibia, S., Priam, M., Bluet-Pajot, M. T., and Kordon, C., 1982a, Neurotensin stimulation of prolactin secretion in vitro, Neuroendocrinology, 34: 95.PubMedCrossRefGoogle Scholar
  17. Enjalbert, A., Arancibia, S., Ruberg, M., Priam, M., Bluet-Pajot, M. T., Rotsztejn, W. H., and Kordon, C., 1980, Stimulation of in vitro prolactin release by vasoactive intestinal peptide, Neuroendocrinology, 31: 200.PubMedCrossRefGoogle Scholar
  18. Enjalbert, A., and Bockaert, J., 1983, Pharmacological characterization of the D2-dopamine receptor negatively coupled with adenylate cyclase in rat anterior pituitary, Mol. Pharmacol. 23: 576.Google Scholar
  19. Enjalbert, A., Epelbaum, J., Arancibia, S., Tapia-Arancibia, L., Bluet-Pajot, M. T., and Kordon, C., 1982b, Reciprocal interactions of SRIF with TRH and VIP on prolactin and growth hormone secretion in vitro, Endocrinology, 111: 42.PubMedCrossRefGoogle Scholar
  20. Enjalbert, A., and Kordon, C., 1982, Neuropeptides and modulation of adenohypophyseal secretions, in: “ Multihormonal Regulations in Neuroendocrine Cells ”, Vol. 110, INSERM, Paris. Enjalbert, A., Rasolonjanahary, R., Moyse, E., Kordon, C., andGoogle Scholar
  21. Epelbaum, J., 1983, Guanine nucleotide sensitivity of [1251] -iodo-NTyr-somatostatin binding in rat adenohypophysis and cerebral cortex, Endocrinology, 113: 822.PubMedCrossRefGoogle Scholar
  22. Enjalbert, A., Ruberg, M., Arancibia, S., Priam, M., Bauer, K., and Kordon, C., 1979a, Inhibition of in vitro prolactin secretion by histidyl-proline-diketopiperazine, a degradation product of TRH, Eur. J. Pharmacol., 58: 97.Google Scholar
  23. Enjalbert, A., Ruberg, M., Fiore, L., Arancibia, S., Priam, M., and Kordon, C., 1979b, Effect of morphine on the dopamine inhibition of pituitary prolactin release in vitro, Eur. J. Pharmacol., 53: 211.Google Scholar
  24. Enjalbert, A., Ruberg, M., Arancibia, S., Priam, M., and Kordon, C., 1979c, Endogenous opiates block dopamine inhibition of prolactin secretion in vitro, Nature, 280: 595.PubMedCrossRefGoogle Scholar
  25. Enjalbert, A., Ruberg, M., Fiore, L., Arancibia, S., Priam, M., and Kordon, C., 1979d, Independent inhibition of prolactin secretion by dopamine and y-amino-butyric acid in vitro, Endocrinology, 105: 823.PubMedCrossRefGoogle Scholar
  26. Enjalbert, A., Tapia-Arancibia, L., Rieutort, M., Brazeau, P., Kordon, C., and Epelbaum, J., 1982c, Somatostatin receptors on rat anterior pituitary membranes, Endocrinology, 110: 1634PubMedCrossRefGoogle Scholar
  27. Frey, E. A., Cote, T. E., Grewe, C. W., and Kebabian, J. W., 1982, 3H-spiroperidol identifies a D2 dopamine receptor inhibiting adenylate cyclase activity in the intermediate lobe of the rat pituitary gland, Endocrinology, 110: 1897.Google Scholar
  28. Giachetti, A., Borghi, C., Nicosia, S., and Said, S. I., 1979, Vasoactive intestinal peptide ( VIP) activates rat pituitary adenylate cyclase, Fed. Proc., 38: 1129.Google Scholar
  29. Giannattasio, G., De Ferrari, M. E., and Spada, A., 1981, Dopamine-inhibited adenylate cyclase in female rat adenohypophysis, Life Sci., 28: 1605.Google Scholar
  30. Gourdji, D., Bataille, D., Vauclin, N., Grouselle, D., Rosselin, G., and Tixier-Vidal, A., 1979, Vasoactive intestinal peptide (VIP) stimulates prolactin (PRL) release and cAMP production in a rat pituitary cell line (GH3/B6). Additive effects of VIP and TRH on PRL release, FEBS Lett., 104: 165.Google Scholar
  31. Gourdji, D., Kerdelhué, B., and Tixier-Vidal, A., 1972, Ultrastructure’d’un clone de cellules hypophysaires sécrétant-de la prolactine (clone GH3). Modification induite par l’hormone de libération de l’hormone thyréotrope (TRF), C. R. Acad. Sci. ( Paris ), 274: 437.Google Scholar
  32. Hill, M. K., Mac Leod, R. M., and Orcutt, P., 1976, Dibutyryl cyclic AMP, adenosine and guanosine blockade of the dopamine, ergocryptine and apomorphine inhibition of prolactin release in vitro, Endocrinology, 99: 1612.PubMedCrossRefGoogle Scholar
  33. Iyengar, R., and Birnbaumer, L., 1982, Hormone receptor modulates the regulatory component of adenylate cyclase by reducing its requirement for Mg++ and enhancing its extens of activation by guanine nucleotides, Proc. Natl. Acad. Sci. ( USA ), 79: 5179.Google Scholar
  34. Kebabian, J. W., and Cagne, C. B., 1979, Multiple receptors for dopamine, Nature, 277: 93.PubMedCrossRefGoogle Scholar
  35. Kraicer, J., and Chow, A. E. H., 1982, Release of growth hormone from purified somatotrophs. Use of perifusion system to elucidate interrelations among Ca++ adenosine, 3’, 5’monophosphate, and somatostatin, Endocrinology, 111: 1173.PubMedCrossRefGoogle Scholar
  36. Login, I. S., and Mac Leod, R. M., 1979, Failure of opiates to reverse dopamine inhibition of prolactin secretion in vitro, Eur. J. Pharmacol., 60: 253.Google Scholar
  37. Mac Leod, R. M., 1969, Influence of norepinephrine and catechola-mines depleting agents on the synthesis and release of prolactin and growth hormone, Endocrinology, 85: 916.CrossRefGoogle Scholar
  38. Maurer, R. A., 1982, Adenosine 3’, 5’-monophosphate derivates increase prolactin synthesis and prolactin messenger ribonucleic acid levels in ergocriptine-treated pituitary cells, Endocrinology, 110: 1957.PubMedCrossRefGoogle Scholar
  39. Meunier, H., and Labrie, F., 1982, The dopamine receptor in the intermediate lobe of the rat pituitary gland is negatively coupled to adenylate cyclase, Life Sci., 30:963.Google Scholar
  40. Motomatsu, T., Lis, M., Seidan, N., and Chretien, M., 1977, Inhibition by beta-endorphin of dopamine sensitive adenylate cyclase in rat striatum, Biochem. Biophys. Res. Commun., 77: 442.Google Scholar
  41. Munemura, M., Cote, T. E., Tsuruta, K., Eskay, R. L., and Kebabian, J. W., 1980, The dopamine receptor in the intermediate lobe of the rat pituitary gland: pharmacological characteristization, Endocrinology, 107: 1676.PubMedCrossRefGoogle Scholar
  42. Northrup, J. K., Smigel, M. D., and Gilman, A. G., 1982, The guanine nucleotide activating site of the regulatory component of adenylate cyclase. Identification by ligand binding, J. Biol. Chem., 257: 11416.Google Scholar
  43. Ojeda, S. R., Harms, P. G., and McCann, S. M., 1974, Possible role of cyclic AMP and prostaglandin E1 in the dopaminergic control of prolactin release, Endocrinology, 95: 1694.PubMedCrossRefGoogle Scholar
  44. Onalli, P., Schwartz, J. P., and Costa, E., 1981, Dopaminergic modulation of adenylate cyclase stimulation by vasoactive intestinal peptide in anterior pituitary, Proc. Natl. Acad. Sci. ( USA ), 78: 6531.Google Scholar
  45. Robberecht, P., Deschodt-Lanckman, M., Camus, J. C., De Neef, P., Lambert, N., and Christophe, J., 1979, VIP activation of rat anterior pituitary adenylate cyclase, FEBS Lett., 103: 229.Google Scholar
  46. Rouleau D., and Barden, N., 1981, Inhibition of anterior pituitary prostaglandin-stimulated adenyl cyclase activity by somatostatin, Can. J. Biochem., 59: 307.Google Scholar
  47. Ruberg, M., Rotsztejn, W. H., Arancibia, S., Besson, J., and Enjalbert, A., 1978, Stimulation of prolactin release by vasoactive intestinal peptide (VIP), Eur. J. Pharmacol., 51: 319.Google Scholar
  48. Schally, A. V., Redding, T. W., Arimura, A., Dupont, A., and Linthicum, G. L., 1977, Isolation of gamma-amino butyric acid from pig hypothalami and demonstration of its prolactin release-inhibiting ( PIF) activity in vivo and in vitro, Endocrinology, 100: 681.Google Scholar
  49. Schettini, G., Cronin, M. J., and Mac Leod, R. M., 1983, Adenosine 3’, 5’-monophosphate (cAMP) and calcium-calmodulin interrelation in the control of prolactin secretion: evidence for dopamine inhibition of cAMP accumulation and prolactin release after calcium mobilization, Endocrinology, 112: 1801.PubMedCrossRefGoogle Scholar
  50. Schonbrunn, A., and Tashjian, A. H., 1982, Modulation of somatosta-tin receptors by thyrotropin releasing hormone in a clonal pituitary strain, J. Biol. Chem., 288: 190.Google Scholar
  51. Sibley, D. R., and Crease, I., 1979, Guanine-nucleotides regulate anterior pituitary dopamine receptors, Eur. J. Pharmacol., 55: 341.Google Scholar
  52. Sibley, D. R., De Lean, A., and Creese, I., 1982, Anterior pituitary dopamine receptors. Demonstration of interconver-tibie high and low affinity states of the D2 dopamine receptor, J. Biol. Chem., 257: 6351.Google Scholar
  53. Swennen, L.,and Denef, C., 1982, Physiological concentrations of dopamine decrease adenosine 3’, 5’-monophosphate levels in cultured rat anterior pituitary cells and enriched populations of lactotrophs: evidence for a causal relationships to inhibition of prolactin release, Endocrinology, 111:398.Google Scholar
  54. Tam, S. W., and Dannies, P. S., The role of adenosine 3’, 5’monophosphate in dopaminergic inhibition of prolactin release in anterior pituitary cells, Endocrinology, 109: 403.Google Scholar
  55. Tang, L. C., and Cotzias, G. C., 1978, Morphine sulfate stimulates adenylate cyclase in mouse caudate nuclei, Proc. Natl. Acad. Sci. (USA), 75:1546.Google Scholar
  56. Tapia-Arancibia, L.,Arancibia, S., Bluet-Pajot, M. T., Enjalbert, A., Epelbaum, J., Priam, M., and Kordon, C., 1980, Effect of vasoactive intestinal peptide (VIP) on somatostatin inhibition of pituitary growth hormone secretion in vitro, Eur. J. Pharmacol., 63:235.Google Scholar
  57. Tashjian, A. H., Barousky, N. J., and Jensen, D. K., 1971, Thyrotropin-releasing hormone: direct evidence for stimulation of prolactin production by pituitary cells in culture, Biochem. Biophys. Res. Commun., 43: 516.Google Scholar
  58. Taylor, D. P., and Pert, C. B., 1979, Vasoactive intestinal polypeptide: specific binding to rat brain membranes, Proc. Natl. Acad. Sci. ( USA ), 76: 660.Google Scholar
  59. Vijayan, E., and McCann, S. M., 1980, In vivo and in vitro effects of substance P and neurotensin on gonadotropin and prolactin release, Endocrinology, 105: 64.CrossRefGoogle Scholar
  60. Westendorf, J. M., and Schonbrunn, A., 1982, Bombesin stimulates prolactin and growth hormone release by pituitary cells in culture, Endocrinology, 110: 352.PubMedCrossRefGoogle Scholar
  61. Wuttke, W., and Düker,’E., 1983, Control of pituitary prolactin release, in: “ Integrative Neurohumoral Mechanisms ”, Endröczi, E. et al. Eds., Elsevier Science Publisher, Amsterdam.Google Scholar

Copyright information

© Springer Science+Business Media New York 1984

Authors and Affiliations

  • Alain Enjalbert
    • 1
  • Joël Bockaert
    • 1
    • 2
  • Jacques Epelbaum
    • 1
  • Emmanuel Moyse
    • 1
  • Claude Kordon
    • 1
  1. 1.Unité 159 de Neuroendocrinologie INSERMParisFrance
  2. 2.Centre CNRS-INSERM de Pharmacologie-EndocrinologieMontpellierFrance

Personalised recommendations